Malaria prophylaxis for long-term travellers.
These guidelines are designed to assist healthcare workers who are advising long-term travellers on malaria prophylaxis, defined for the purpose of this document as those travelling for longer than 6 months. The document focuses on long-term use of antimalarials for adults, but also identifies specific issues for women and children. However, data on the long-term use of antimalarials is limited for all travellers and few data are available on the incidence of malaria in travellers overseas or, indeed, deaths overseas from malaria. Whilst all available evidence is taken into account, the advice provided also reflects experienced professional opinion. This document has been written on behalf of the Health Protection Agency's Advisory Committee on Malaria Prevention for UK Travellers, and is designed to act as a supplement to the 'Guidelines for malaria prevention in travellers from the United Kingdom for 2003'. The latter document contains a more complete description of antimalarials and additional preventive measures, together with recommendations for malaria chemoprophylaxis for individuals countries. Decisions on the terms under which different drugs are licensed for use are the responsibility of the Committee on Safety of Medicines. This paper should also, therefore, be used in conjunction with Summary of Product Characteristics (data sheets).
Hughes
C
C
Health Protection Agency, Colindale.
Tucker
R
R
Bannister
B
B
Bradley
D J
DJ
D000328:Adult; D000962:Antimalarials / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002648:Child; D005260:Female; D006207:Half-Life; D006801:Humans; D008288:Malaria / Q000209:etiology / Q000517:prevention & control*; D018570:Risk Assessment; D013997:Time Factors; D014195:Travel; D006113:United Kingdom
D000962:Antimalarials